Tradestie Institutional Equity Comparison Engine

EDIT vs BEAM โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

EDIT Overall Edge

EDIT Captures Institutional Edge (2โ€“1 Pillars ยท 4โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Editas Medicine, Inc. Common Stock (EDIT) driven by superior Growth & Margin, Options & Structure while BEAM counters with relative strength in Momentum & Technical. Fundamentally, EDIT trades at N/M Forward P/E with -167.0% operating margin (+37.4% YoY revenue) versus BEAM at N/M Forward P/E and -267.7% operating margin (-96.8% YoY). In options structure, EDIT sits in BREAKDOWN (38th %ile IV; Dealer Gamma Walls on Pro) against BEAM sits in BREAKDOWN (42nd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
EDIT N/M vs BEAM N/M Fwd P/E
Growth & Margin Winner EDIT
Op Margin -167.0% vs -267.7% ยท YoY +37.4% vs -96.8%
Momentum & Technical Winner BEAM
1Y -25.0% vs -1.7% ยท 52W Pos 11% vs 6%
Options & Structure Winner EDIT
BREAKDOWN (38th %ile IV) vs BREAKDOWN (42nd %ile IV)
EDIT NASDAQ
Editas Medicine, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$1.91
-12.21% 1D
Market Cap $336.5M
1M Return -18.94%
1Y Return -25.0%
Forward P/E N/M
Unified AI Score
51.6 / 100 HOLD
Tech 40.0 Fund 54.0 Flow 69.0 Mom 60.0
BEAM NASDAQ
Beam Therapeutics Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$21.29
-6.75% 1D
Market Cap $2.4B
1M Return -9.29%
1Y Return -1.71%
Forward P/E N/M
Unified AI Score
45.9 / 100 HOLD
Tech 30.0 Fund 52.0 Flow 70.0 Mom 70.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: EDIT -25.0% BEAM -1.71% Spread: +23.29 pp (BEAM Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period EDIT Revenue BEAM Revenue EDIT Op. Margin BEAM Op. Margin Margin Edge
FY2018 $30M N/A -356.1% N/A EDIT
FY2019 $20M $0M -686.4% -417522.2% EDIT
FY2020 $90M $0M -148.6% -553166.7% EDIT
FY2021 $30M $50M -756.1% -757.0% EDIT
FY2022 $20M $60M -1146.3% -555.6% BEAM
FY2023 $80M $380M -216.6% -46.7% BEAM
FY2024 $30M $60M -777.2% -654.3% BEAM
FY2025 $40M $140M -394.9% -274.6% BEAM

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: EDIT (4) vs BEAM (4)
Institutional Metric EDIT BEAM Criterion Row Winner
Market Capitalization Scale $336.5M $2.4B Larger Scale BEAM
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +37.4% -96.8% Higher Growth EDIT
Operating Margin (TTM) Profitability -167.0% -267.7% Higher Margin EDIT
Net Profit Margin Profitability -144.9% -73.9% Higher Margin BEAM
Return on Equity (ROE) Capital Efficiency -147.4% -11.3% Higher ROE BEAM
52-Week Range Position Momentum 11% ($2โ€“$4) 6% ($20โ€“$38) Stronger Trend EDIT
Beta / 30D Volatility Risk Regime 2.32ฮฒ ยท 102% Vol 2.24ฮฒ ยท 86% Vol Lower Realized Risk BEAM
Unified Institutional Score Composite Signal 51.6 / 100 (HOLD) 45.9 / 100 (HOLD) Higher Composite EDIT

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full EDIT vs BEAM Buy Guide
EDIT BREAKDOWN
146d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 38th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live EDIT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
BEAM BREAKDOWN
103d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 42nd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live BEAM Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither EDIT nor BEAM registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.